National Pension Service grew its holdings in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 10.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,369,149 shares of the company’s stock after purchasing an additional 310,824 shares during the quarter. National Pension Service’s holdings in Kenvue were worth $64,384,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in KVUE. BlackRock Inc. purchased a new stake in Kenvue during the second quarter valued at approximately $2,882,279,000. State Street Corp grew its position in shares of Kenvue by 3.5% during the 4th quarter. State Street Corp now owns 118,865,134 shares of the company’s stock valued at $2,050,424,000 after acquiring an additional 4,063,257 shares during the period. California State Teachers Retirement System increased its stake in shares of Kenvue by 1,695.1% in the 2nd quarter. California State Teachers Retirement System now owns 56,438,843 shares of the company’s stock worth $1,078,546,000 after purchasing an additional 53,294,807 shares in the last quarter. Pentwater Capital Management LP bought a new position in Kenvue in the 2nd quarter worth $977,094,000. Finally, Geode Capital Management LLC lifted its position in Kenvue by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock valued at $856,778,000 after purchasing an additional 371,322 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Wall Street Analyst Weigh In
KVUE has been the subject of a number of analyst reports. UBS Group reduced their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday, August 11th. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Finally, Barclays upped their target price on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $19.27.
Kenvue Trading Down 0.3%
Shares of Kenvue stock opened at $17.73 on Friday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $20.13. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The business has a 50-day moving average price of $19.05 and a 200-day moving average price of $18.24. The firm has a market cap of $34.06 billion, a price-to-earnings ratio of 20.39, a PEG ratio of 1.59 and a beta of 0.46.
Kenvue (NYSE:KVUE – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. During the same period last year, the business posted $0.29 earnings per share. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.
Kenvue Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 2nd. Shareholders of record on Monday, September 21st will be given a dividend of $0.21 per share. The ex-dividend date is Monday, September 21st. This represents a $0.84 dividend on an annualized basis and a yield of 4.7%. Kenvue’s dividend payout ratio is 96.55%.
About Kenvue
Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.
The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health.
Further Reading
- Five stocks we like better than Kenvue
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
